Parameter | Asymptomatic patients (No.[%]) | Symptomatic patients (No. [%]) | P |
---|---|---|---|
Number of patients | 149 | 456 | Â |
Patients with endometrioid endometrial cancer | 133 | 410 | Â |
Age at first diagnosis (years SD ) | 66.3 (10.3) | 67.1 (11.2) | 0.9* |
Tumor stage |  |  | 0.07†|
I | 100 (75.2) | 286 (69.8) | Â |
II | 9 (6.8) | 40 (9.8) | Â |
III | 15 (11.2) | 71 (17.2) | Â |
IV | 9 (6.8) | 13 (3.2) | Â |
Tumor grade |  |  | 0.006†|
G1 | 74 (55.7) | 170 (41.5) | Â |
G2 | 45 (33.8) | 153 (37.3) | Â |
G3 | 14 (10.5) | 87 (21.2) | Â |
Patients with follow-up information available | 133 | 409 | Â |
Time of follow-up (months [SD]) | 23.7 (24.03) | 28.5 (25.76) | 0.06* |
Recurrence status | Â | Â | Â |
Patients with recurrent disease | 14 (10.5) | 55 (13.4) | 0.2†|
Time to recurrent disease (months [SD]) | 18.5 (16.9) | 20.4 (17.6) | 0.7* |
Status at last observation |  |  | 0.7†|
Alive with no evidence of disease | 115 (86.5) | 341 (83.4) | Â |
Stable disease | 0 | 3 (0.7) | Â |
Progressive disease | 8 (6.0) | 34 (8.3) | Â |
Dead as a result of disease | 9 (6.8) | 25 (6.1) | Â |
Dead as a result of other causes | 1 (0.7) | 6 (1.5) | Â |